FDA.reportPublic FDA data

Application 090675

Type
ANDA
Sponsor
JIANGSU HENGRUI MED

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001IRINOTECAN HYDROCHLORIDEIRINOTECAN HYDROCHLORIDEINJECTABLE;INJECTION100MG/5ML (20MG/ML)NoNo
002IRINOTECAN HYDROCHLORIDEIRINOTECAN HYDROCHLORIDEINJECTABLE;INJECTION40MG/2ML (20MG/ML)NoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
25021-230Irinotecan Hydrochlorideirinotecan hydrochlorideSagent PharmaceuticalsANDACurrent
25021-230Irinotecan Hydrochlorideirinotecan hydrochlorideSagent PharmaceuticalsANDACurrent
25021-230Irinotecan Hydrochlorideirinotecan hydrochlorideSagent PharmaceuticalsANDACurrent
25021-230Irinotecan Hydrochlorideirinotecan hydrochlorideSagent PharmaceuticalsANDACurrent
25021-230Irinotecan Hydrochlorideirinotecan hydrochlorideSagent PharmaceuticalsANDACurrent
25021-230Irinotecan Hydrochlorideirinotecan hydrochlorideSagent PharmaceuticalsANDACurrent